RFK Jr. on Ozempic, Eli Lilly's next test, and Elon Musk gets on the bandwagon: Pharma news roundup - PCB levies 31L penalty on pharma manufacturing unit over violations - Healthy Returns: Trump's FDA pick Makary may be a relief for biotech and pharma, analysts say - Ozempic cuts drinking, Zepbound beats Wegovy, and a blood test detects 50 cancers: Pharma news roundup - T govt scraps pharma city plan amid protests, announces textile corridor - No pharma city, Kodangal to have industrial corridor: CM - T'gana pharma biggies to inject 5,200cr in Pharma City, create over 12,000 jobs - Pharma shares hit as Trump picks RFK Jr to lead health department - What the NFL Draft Can Teach Investors About Big Pharma - 'Pharma City to be ready for units to set up shop in 1 year'

Pharmadar

6 days ago

Bookmark

Share

Pharmadar is a company. It was founded in 2013. The company is part of the Health Care sector, specifically in the Pharmaceuticals industry.

Key facts

sector: Health Care
industry: Pharmaceuticals
foundation year: 2013

Classified as: organization

Business

Pharmadar is one of the companies in Pharmaceuticals, companies in Health Care and 3,550,070 companies in our database.

Employees: Try Pro to see estimates
Revenues: Try Pro to see estimates

Stocks from Pharmadar:

In literature

There is no book written about Pharmadar in the database.

Related

Connected or similar to Pharmadar:

Details

This dashboard is based on data from: YAHOO-FIN, YFINANCE, Twitter.

This content is available under the CC BY 4.0 license.